Plexium scores $35m

Plexium Inc, a developer of protein degrading therapeutics directed towards historically challenging drug targets, has secured $35 million in financing.

Plexium Inc, a developer of protein degrading therapeutics directed towards historically challenging drug targets, has secured $35 million in financing. Lux Capital and Pivotal BioVentures led the round.

Source: Press Release